These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32451660)

  • 1. Ovarian stimulation after dehydroepiandrosterone supplementation in poor ovarian reserve: a randomized clinical trial.
    Elprince M; Kishk EA; Metawie OM; Albiely MM
    Arch Gynecol Obstet; 2020 Aug; 302(2):529-534. PubMed ID: 32451660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
    Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
    J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.
    Yeung T; Chai J; Li R; Lee V; Ho PC; Ng E
    BJOG; 2016 Jun; 123(7):1097-105. PubMed ID: 26663817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
    Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
    Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial.
    Zhang HH; Xu PY; Wu J; Zou WW; Xu XM; Cao XY; Wei LZ
    J Ovarian Res; 2014 Oct; 7():93. PubMed ID: 25330837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
    Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
    Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
    Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism.
    Hyman JH; Margalioth EJ; Rabinowitz R; Tsafrir A; Gal M; Alerhand S; Algur N; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):49-53. PubMed ID: 23312476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
    Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve.
    Gat I; Blanco Mejia S; Balakier H; Librach CL; Claessens A; Ryan EA
    Gynecol Endocrinol; 2016 Jul; 32(7):534-7. PubMed ID: 26829445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dehydroepiandrosterone supplementation on mice with diminished ovarian reserve.
    Lin X; Du J; Du Y; Wu R; Fang X; Liao Y; Quan S
    Gynecol Endocrinol; 2018 Apr; 34(4):357-359. PubMed ID: 29221424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
    Wong QHY; Yeung TWY; Yung SSF; Ko JKY; Li HWR; Ng EHY
    J Assist Reprod Genet; 2018 May; 35(5):857-862. PubMed ID: 29520734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.
    Zhang M; Niu W; Wang Y; Xu J; Bao X; Wang L; Du L; Sun Y
    J Assist Reprod Genet; 2016 Aug; 33(8):981-91. PubMed ID: 27094195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
    Yeung TW; Li RH; Lee VC; Ho PC; Ng EH
    J Clin Endocrinol Metab; 2013 Jan; 98(1):380-8. PubMed ID: 23144466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study.
    Barad DH; Kushnir VA; Lee HJ; Lazzaroni E; Gleicher N
    Reprod Biol Endocrinol; 2014 Jul; 12():68. PubMed ID: 25048047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders.
    Triantafyllidou O; Sigalos G; Vlahos N
    Hum Fertil (Camb); 2017 Jun; 20(2):80-87. PubMed ID: 27927044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.
    Zangmo R; Singh N; Kumar S; Vanamail P; Tiwari A
    Reprod Biomed Online; 2014 Jun; 28(6):743-7. PubMed ID: 24745834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.